Speaker "Erick Diaz Outten" Details Back



Data Science: Commercial options for biotech in rare diseases


Compared to therapy areas where patients have multiple treatment options for improving their quality of life (i.e Diabetes, HIV, MS, etc.), the rare disease space faces more challenges in reaching the right physicians (with rare disease patients). Most of those challenges are related to education at the physician, patient and payer levels, as well as industry-related development (diagnosis awareness and standardization), among others. In my presentation, I will demonstrate that those challenges are not necessarily a liability but can actually be turned to an advantage with the creation of a uniquely effective commercial organization able to put the patient at the center while successfully reaching the right physicians, and helping them to diagnose and treat in a timely manner and before adverse events occur.



Erick Diaz Outten is a commercial expert on analytics on sales and marketing science, with experience in the consulting and corporate side of the business, having worked with multiple pharmaceutical and biotechs clients on strategy and tactics. Mr. Diaz received his Master Degree in Operation Research and Information Engineering from Cornell University. Prior to joining Alexion Pharmaceuticals, he worked for Biogen, and for the consulting side of the pharmaceutical industry at ZS Associates. Before working on the pharmaceutical industry, he worked in information management for the Energy and Mining sectors in his native Peru, and was also an adjunct professor of Operations Research at Lima's National University of Engineering.